Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1986 Sep;59(1):57–61.

Synergy between interleukin-2 and a second factor in the long-term growth of human T cells.

B J Mills, J E Shively, P S Mitsky, D H Hawke, S J Forman, C L Wright, C W Todd
PMCID: PMC1453126  PMID: 3489670

Abstract

It has recently been shown that factors in addition to interleukin-2 (IL-2) are required for the proliferation or differentiation of at least some murine T-cell lines. We have previously shown that conditioned medium from human mononuclear cells stimulated with phorbol ester and staphylococcal enterotoxin A is superior to commercial sources of IL-2 for the long-term growth of human T cells. We have identified in these supernatants a non-IL-2 factor (synergistic factor, SF) which synergizes with JURKAT IL-2 in the long-term growth of human T cells. [3H]TdR incorporation by IL-2-dependent human T cells after growth in IL-2 or SF alone for 14 days was slight, but significant. By contrast, growth in a combination of SF and IL-2 for 14 days stimulated [3H]TdR incorporation 10-20-fold higher, generally equal to the high incorporation measured when cells were grown in the presence of the conditioned medium from which SF was obtained. In a standard 2-day IL-2 assay, there was no correlation between activity and long-term growth-promoting ability. These results suggest that the 14-day assay better discerns the growth-promoting activity of various factors or combinations of factors. The mechanism of this interaction between SF and IL-2 remains to be elucidated. It is clear, however, that T-cell growth factor activity, when assessed by the long-term growth of human T cells, is not due to interleukin-2 alone.

Full text

PDF
60

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrew M. E., Braciale V. L., Braciale T. J. Regulation of interleukin 2 receptor expression on murine cytotoxic T lymphocyte clones. J Immunol. 1984 Feb;132(2):839–844. [PubMed] [Google Scholar]
  2. Cantrell D. A., Smith K. A. The interleukin-2 T-cell system: a new cell growth model. Science. 1984 Jun 22;224(4655):1312–1316. doi: 10.1126/science.6427923. [DOI] [PubMed] [Google Scholar]
  3. Finke J. H., Scott J., Gillis S., Hilfiker M. L. Generation of alloreactive cytotoxic T lymphocytes: evidence for a differentiation factor distinct from IL 2. J Immunol. 1983 Feb;130(2):763–767. [PubMed] [Google Scholar]
  4. Garman R. D., Fan D. P. Characterization of helper factors distinct from interleukin 2 necessary for the generation of allospecific cytolytic T lymphocytes. J Immunol. 1983 Feb;130(2):756–762. [PubMed] [Google Scholar]
  5. Gillis S., Baker P. E., Ruscetti F. W., Smith K. A. Long-term culture of human antigen-specific cytotoxic T-cell lines. J Exp Med. 1978 Oct 1;148(4):1093–1098. doi: 10.1084/jem.148.4.1093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol. 1978 Jun;120(6):2027–2032. [PubMed] [Google Scholar]
  7. Glasebrook A. L., Fitch F. W. Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines. J Exp Med. 1980 Apr 1;151(4):876–895. doi: 10.1084/jem.151.4.876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hapel A. J., Lee J. C., Farrar W. L., Ihle J. N. Establishment of continuous cultures of thy1.2+, Lyt1+, 2-T cells with purified interleukin 3. Cell. 1981 Jul;25(1):179–186. doi: 10.1016/0092-8674(81)90242-7. [DOI] [PubMed] [Google Scholar]
  9. Lamb J. R., Eckels D. D., Lake P., Johnson A. H., Hartzman R. J., Woody J. N. Antigen-specific human T lymphocyte clones: induction, antigen specificity, and MHC restriction of influenza virus-immune clones. J Immunol. 1982 Jan;128(1):233–238. [PubMed] [Google Scholar]
  10. Lutz C. T., Glasebrook A. L., Fitch F. W. Alloreactive cloned T cell lines. III. Accessory cell requirements for the growth of cloned cytolytic T lymphocytes. J Immunol. 1981 Apr;126(4):1404–1408. [PubMed] [Google Scholar]
  11. Mills B. J., Mitsky P. S., Todd C. W. Acid treatment enhances IL-2 activity of conditioned medium. J Immunol Methods. 1984 Feb 24;67(1):73–78. doi: 10.1016/0022-1759(84)90086-3. [DOI] [PubMed] [Google Scholar]
  12. Olabuenaga S. E., Brooks C. G., Gillis S., Henney C. S. Interleukin 2 is not sufficient for the continuous growth of cloned NK-like cytotoxic cell lines. J Immunol. 1983 Nov;131(5):2386–2391. [PubMed] [Google Scholar]
  13. Raulet D. H., Bevan M. J. A differentiation factor required for the expression of cytotoxic T-cell function. Nature. 1982 Apr 22;296(5859):754–757. doi: 10.1038/296754a0. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES